These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 31315214)
1. Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Shin JH; Chaplin AS; Hays RA; Kolling GL; Vance S; Guerrant RL; Archbald-Pannone L; Warren CA J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31315214 [TBL] [Abstract][Full Text] [Related]
2. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials. Madoff SE; Urquiaga M; Alonso CD; Kelly CP Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500 [TBL] [Abstract][Full Text] [Related]
3. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease. Cho S; Spencer E; Hirten R; Grinspan A; Dubinsky MC J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):343-347. PubMed ID: 30320666 [TBL] [Abstract][Full Text] [Related]
4. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure. Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961 [TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis. Porcari S; Baunwall SMD; Occhionero AS; Ingrosso MR; Ford AC; Hvas CL; Gasbarrini A; Cammarota G; Ianiro G J Autoimmun; 2023 Dec; 141():103036. PubMed ID: 37098448 [TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes. Girotra M; Garg S; Anand R; Song Y; Dutta SK Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476 [TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome. Gotoh K; Sakaguchi Y; Kato H; Osaki H; Jodai Y; Wakuda M; Také A; Hayashi S; Morita E; Sugie T; Ito Y; Ohmiya N Anaerobe; 2022 Feb; 73():102502. PubMed ID: 34896553 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection. Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405 [TBL] [Abstract][Full Text] [Related]
9. Recurrent Mehta N; Goodenough D; Gupta NK; Thomas S; Mehta C; Prakash R; Woodworth MH; Kraft CS; Fridkin SK Open Forum Infect Dis; 2024 Jul; 11(7):ofae309. PubMed ID: 38975247 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Ali H; Khurana S; Ma W; Peng Y; Jiang ZD; DuPont H; Zhang HC; Thomas AS; Okhuysen P; Wang Y J Cancer; 2021; 12(21):6498-6506. PubMed ID: 34659541 [No Abstract] [Full Text] [Related]
12. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent van Lingen EE; Baunwall SSMD; Lieberknecht SSC; Benech NN; Ianiro GG; Sokol HH; Gasbarrini AA; Cammarota GG; Eriksen MMK; van der Meulen-de Jong AAE; Terveer EEM; Verspaget HHW; Vehreschild MM; Hvas CCL; Keller JJJ Therap Adv Gastroenterol; 2023; 16():17562848231156285. PubMed ID: 36910163 [TBL] [Abstract][Full Text] [Related]
13. Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome. Yeh YM; Cheng HT; Le PH; Chen CC; Kuo CJ; Chen CL; Chiu CT; Chiu CH Biomed J; 2022 Jun; 45(3):504-511. PubMed ID: 34118466 [TBL] [Abstract][Full Text] [Related]
14. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection. Mamo Y; Woodworth MH; Wang T; Dhere T; Kraft CS Clin Infect Dis; 2018 May; 66(11):1705-1711. PubMed ID: 29272401 [TBL] [Abstract][Full Text] [Related]
16. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway. Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484 [TBL] [Abstract][Full Text] [Related]
17. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals. Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106 [TBL] [Abstract][Full Text] [Related]
18. Alternative Diagnoses in Pediatric Fecal Microbiota Transplant Referral Patients. Ruan W; Kellermayer R J Pediatr Gastroenterol Nutr; 2021 May; 72(5):693-696. PubMed ID: 33534360 [TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Gholam-Mostafaei FS; Azimirad M; Naseri K; Nabavi-Rad A; Asadzadeh Aghdaei H; Shahrokh S; Ebrahimi Daryani N; Yadegar A; Zali MR Front Microbiol; 2023; 14():1147945. PubMed ID: 36910213 [TBL] [Abstract][Full Text] [Related]